BRISTOL-MYERS SQUIBB COMPANY Severance Costs (Deprecated 2013-01-31)
BRISTOL-MYERS SQUIBB COMPANY (BMY) reported Severance Costs (Deprecated 2013-01-31) of $172.00 million for the 3-month period ending 2013-06-30, per its 10-Q filed 2013-07-25.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SeveranceCosts · last filed 2013-07-25
- BRISTOL-MYERS SQUIBB COMPANY severance costs (deprecated 2013-01-31) for the quarter ending 2013-06-30 was $172.00M, a 975.00% increase year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY severance costs (deprecated 2013-01-31) for the quarter ending 2013-03-31 was $29.00M, a 52.63% increase year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY severance costs (deprecated 2013-01-31) for the quarter ending 2012-12-31 was $89.00M, a 584.62% increase year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY severance costs (deprecated 2013-01-31) for the quarter ending 2012-09-30 was $21.00M, a 425.00% increase year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY severance costs (deprecated 2013-01-31) for fiscal 2012 was $145.00M, a 70.59% increase from fiscal 2011.
- BRISTOL-MYERS SQUIBB COMPANY severance costs (deprecated 2013-01-31) for fiscal 2011 was $85.00M, a 16.67% decline from fiscal 2010.
- BRISTOL-MYERS SQUIBB COMPANY severance costs (deprecated 2013-01-31) for fiscal 2010 was $102.00M, a 20.31% decline from fiscal 2009.
- BRISTOL-MYERS SQUIBB COMPANY severance costs (deprecated 2013-01-31) for fiscal 2009 was $128.00M.
| Period end | Severance Costs (Deprecated 2013-01-31) 3 month | Severance Costs (Deprecated 2013-01-31) 6 month | Severance Costs (Deprecated 2013-01-31) 9 month | Severance Costs (Deprecated 2013-01-31) 12 month |
|---|---|---|---|---|
| 2013-06-30 | $172.00M 10-Q · filed 2013-07-25 | $201.00M 10-Q · filed 2013-07-25 | $290.00M derived: sum of 3 quarters · filed 2013-07-25 | $311.00M derived: sum of 4 quarters · filed 2013-07-25 |
| 2013-03-31 | $29.00M 10-Q · filed 2013-04-25 | $118.00M derived: sum of 2 quarters · filed 2013-04-25 | $139.00M derived: sum of 3 quarters · filed 2013-04-25 | $155.00M derived: sum of 4 quarters · filed 2013-07-25 |
| 2012-12-31 | $89.00M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-15 | $110.00M derived: sum of 2 quarters · filed 2013-02-15 | $126.00M derived: sum of 3 quarters · filed 2013-07-25 | $145.00M 10-K · filed 2013-02-15 |
| 2012-09-30 | $21.00M 10-Q · filed 2012-10-24 | $37.00M derived: sum of 2 quarters · filed 2013-07-25 | $56.00M 10-Q · filed 2012-10-24 | $69.00M derived: sum of 4 quarters · filed 2013-07-25 |
| 2012-06-30 | $16.00M 10-Q · filed 2013-07-25 | $35.00M 10-Q · filed 2013-07-25 | $48.00M derived: sum of 3 quarters · filed 2013-07-25 | $52.00M derived: sum of 4 quarters · filed 2013-07-25 |
| 2012-03-31 | $19.00M 10-Q · filed 2013-04-25 | $32.00M derived: sum of 2 quarters · filed 2013-04-25 | $36.00M derived: sum of 3 quarters · filed 2013-04-25 | $61.00M derived: sum of 4 quarters · filed 2013-04-25 |
| 2011-12-31 | $13.00M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-15 | $17.00M derived: sum of 2 quarters · filed 2013-02-15 | $42.00M derived: sum of 3 quarters · filed 2013-02-15 | $85.00M 10-K · filed 2013-02-15 |
| 2011-09-30 | $4.00M 10-Q · filed 2012-10-24 | $29.00M derived: sum of 2 quarters · filed 2012-10-24 | $72.00M 10-Q · filed 2012-10-24 | $134.00M derived: sum of 4 quarters · filed 2013-02-15 |
| 2011-06-30 | $25.00M 10-Q · filed 2012-07-25 | $68.00M 10-Q · filed 2012-07-25 | $130.00M derived: sum of 3 quarters · filed 2013-02-15 | $133.00M derived: sum of 4 quarters · filed 2013-02-15 |
| 2011-03-31 | $43.00M 10-Q · filed 2012-04-26 | $105.00M derived: sum of 2 quarters · filed 2013-02-15 | $108.00M derived: sum of 3 quarters · filed 2013-02-15 | $135.00M derived: sum of 4 quarters · filed 2013-02-15 |
| 2010-12-31 | $62.00M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-15 | $65.00M derived: sum of 2 quarters · filed 2013-02-15 | $92.00M derived: sum of 3 quarters · filed 2013-02-15 | $102.00M 10-K · filed 2013-02-15 |
| 2010-09-30 | $3.00M 10-Q · filed 2011-10-27 | $30.00M derived: sum of 2 quarters · filed 2011-10-27 | $40.00M 10-Q · filed 2011-10-27 | |
| 2010-06-30 | $27.00M 10-Q · filed 2011-07-28 | $37.00M 10-Q · filed 2011-07-28 | ||
| 2010-03-31 | $10.00M 10-Q · filed 2011-04-28 | |||
| 2009-12-31 | $128.00M 10-K · filed 2012-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |